Which medications are linked to macular degeneration
Several medications can damage the macula—the part of your retina responsible for central vision—either as a known side effect or through long-term use. The most common culprits are hydroxychloroquine (used for lupus and rheumatoid arthritis), tamoxifen (a breast cancer treatment), ethambutol (a tuberculosis drug), and high-dose niacin (vitamin B3, sometimes prescribed for cholesterol). Other medications including certain antipsychotics, some immunosuppressants, and particular chemotherapy agents have also been associated with macular damage in some patients.
The risk varies widely depending on the drug, the dose you take, how long you take it, and your individual factors. Some medications cause damage only at high doses or after years of use, while others pose risk even at standard doses. If you take any of these medications, this does not mean you will develop macular degeneration—but your eye doctor should monitor you.
The damage these drugs cause is sometimes reversible if caught early and the medication is stopped, but in other cases it becomes permanent. This is why regular eye exams are critical if you are on a medication known to affect the macula.
Key Takeaways
- Hydroxychloroquine, tamoxifen, ethambutol, and high-dose niacin are the medications most commonly linked to macular damage.
- Risk depends on the specific drug, the dose, how long you take it, and your individual health factors.
- Some macular damage from medications is reversible if the drug is stopped early, but other damage becomes permanent.
- If you take a medication known to affect the macula, your eye doctor should perform regular screening exams to catch changes before vision loss occurs.
- Never stop a prescribed medication on your own; talk to your prescribing doctor and eye doctor about your concerns.
Hydroxychloroquine and other antimalarial drugs
Hydroxychloroquine is prescribed for autoimmune conditions like lupus, rheumatoid arthritis, and Sjögren's syndrome. It can accumulate in the retina over time and cause a pattern of damage that typically starts in the central macula. The risk increases significantly after five years of use and at cumulative doses above 5 milligrams per kilogram of body weight per day.
Your eye doctor may recommend a baseline eye exam before you start hydroxychloroquine, then regular screening exams—often annually or every two years—to watch for early signs of macular damage. Early detection can sometimes allow your doctor to switch you to a different medication before vision loss becomes noticeable. The related drug chloroquine, used less commonly now, carries an even higher risk of macular damage than hydroxychloroquine.
Tamoxifen and cancer medications
Tamoxifen, a hormone therapy used to treat and prevent breast cancer, can deposit in the retina and cause crystalline deposits and macular damage. The risk rises with higher cumulative doses and longer treatment duration. Some patients develop symptoms like blurred central vision or difficulty reading, while others have no symptoms and damage is found only on eye exam.
Other cancer medications including pentostatin, interferon-alpha, and certain chemotherapy agents have been reported to cause macular problems in some patients. If you are undergoing cancer treatment, discuss with your oncologist and eye doctor whether your specific medications carry macular risk and what screening schedule makes sense for you.
Ethambutol and tuberculosis treatment
Ethambutol, a first-line drug for tuberculosis, can cause optic nerve and macular damage, particularly at higher doses or with prolonged use. The damage typically affects color vision first—patients often notice that red objects look less vivid—before central vision changes become apparent. This early warning sign is why your eye doctor will ask about color vision changes if you are on ethambutol.
The risk is dose-dependent: doses above 25 milligrams per kilogram of body weight per day carry substantially higher risk than standard doses. If you need ethambutol, your doctor will balance the need to treat tuberculosis against the eye risk, and regular vision checks are standard during treatment.
Niacin and other vitamin supplements at high doses
Niacin (vitamin B3) at high doses—typically 3 grams per day or more, prescribed for cholesterol or triglyceride management—has been linked to macular edema (swelling) and vision changes in some patients. Unlike the other medications on this list, niacin is available over the counter, which means some people take high doses without medical supervision. If you are taking high-dose niacin, your eye doctor should know.
Other supplements and vitamins at very high doses can theoretically affect the macula, but the risk is generally lower than with prescription medications. The key difference is that high-dose niacin is often prescribed by doctors specifically for cardiovascular health, so the risk-benefit calculation is part of your treatment plan.
Antipsychotics and psychiatric medications
Some antipsychotic medications, particularly thioridazine (an older antipsychotic now rarely used) and potentially others in this class, have been associated with retinal and macular deposits. The risk varies by specific medication and dose. Newer antipsychotics generally carry lower risk than older ones, but your psychiatrist and eye doctor should communicate about any concerns.
If you take an antipsychotic medication long-term, a baseline eye exam and periodic follow-up exams are reasonable precautions. Do not stop or change psychiatric medication without talking to your prescribing doctor, as the benefit of treating your condition usually outweighs the eye risk—but monitoring allows early detection if problems develop.
What to do if you take one of these medications
If you are currently taking any medication linked to macular damage, the first step is to tell both your primary care doctor and your eye doctor. Bring a list of all medications, including doses and how long you have been taking them. Your eye doctor can then decide whether baseline screening is needed and how often you should return for follow-up exams.
Do not stop taking a prescribed medication because of macular risk without discussing it with your prescribing doctor first. In many cases, the medication is treating a serious condition, and the actual risk to your macula is low or manageable with monitoring. Your doctors can weigh the benefits against the risks and may adjust your dose, switch you to a safer alternative, or recommend more frequent eye exams.
If your eye doctor finds early signs of macular damage, stopping or reducing the medication may halt or even partially reverse the damage—but this decision must involve your prescribing doctor. Some conditions cannot be safely managed without the medication, even if it carries eye risk.
Frequently Asked Questions
If I take hydroxychloroquine, will I definitely get macular degeneration?
No. Many people take hydroxychloroquine for years without developing macular damage. Risk increases with higher doses and longer use, but it is not inevitable. Regular eye exams catch early changes before they affect your vision, and stopping the medication early can sometimes prevent further damage.
Can macular damage from medications be reversed?
Sometimes, but not always. Early damage caught before vision loss occurs may improve or stabilize if the medication is stopped. Damage that has already caused vision loss is usually permanent. This is why screening exams are important—they find changes before they affect how you see.
How often should I have eye exams if I take a medication linked to macular damage?
This depends on the specific medication, your dose, how long you have been taking it, and your eye doctor's findings. A baseline exam before starting the medication is common, then follow-up exams ranging from every one to two years. Your eye doctor will recommend the right schedule for you.
What if my eye doctor finds macular changes but I need to keep taking the medication?
Talk with both your eye doctor and prescribing doctor. They may reduce your dose, switch you to a different medication with lower eye risk, or recommend more frequent monitoring. Sometimes the benefit of the medication outweighs the eye risk, and close watching is the best approach.
Are over-the-counter versions of these medications as risky as prescription versions?
High-dose niacin is available over the counter and carries the same macular risk as prescription niacin. Other medications on this list are prescription-only. If you are taking high-dose supplements or vitamins, mention them to your eye doctor so they have a complete picture of what you are taking.